Pharmaceuticals

Global Interleukin Inhibitors Market Overview And Prospects

November 22, 2021 by The Business Research Company

Learn about the global interleukin inhibitors market through The Business Research Company, which provides information on interleukin inhibitors market size, interleukin inhibitors market drivers and restraints, interleukin inhibitors market players, the COVID-19 impact on the interleukin inhibitors market, and more.

Our annual holiday sale is here! Get your discounted market research reports today.

The global interleukin inhibitors market is expected to grow from $17.73 billion in 2020 to $19.88 billion in 2021 at a compound annual growth rate (CAGR) of 12.1%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The interleukin inhibitors market is expected to reach $32 billion in 2025 at a CAGR of 13%.

An increase in the number of investigational drugs for inflammatory diseases such as psoriasis, arthritis, and inflammatory bowel disease is expected to drive innovation in interleukin inhibitors manufacturing, thus driving the market during the forecast period.

Request A Sample For The Global Interleukin Inhibitors Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3469&type=smph

The interleukin inhibitors market consists of the sales of interleukin inhibitors such as interleukin -1, interleukin -5, interleukin -6, interleukin -17, interleukin 23, by companies that manufacture them. These interleukin inhibitors are used for the treatment of autoimmune and inflammatory disorders such as psoriasis, psoriatic arthritis, rheumatoid arthritis, asthma, and inflammatory bowel disease.

Global interleukin inhibitors market segments include:

By Type: IL-17, IL-23, IL-1, IL-5, IL-6, Others

By Application: Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease, Others

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Patent expiry of biologic drugs is opening opportunities for biosimilar drugs, which are a cheap alternative. Major companies in the interleukins sector are focusing on developing biosimilars for interleukin inhibitors.

TBRC’s interleukin inhibitors market report covers:

Major Market Players: Sanofi, GlaxoSmithKline, Novartis, Johnson & Johnson, Roche, Eli Lilly, AstraZeneca, Teva Pharmaceutical, and Regeneron Pharmaceuticals.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)

The Interleukin Inhibitors Global Market Report 2021: COVID-19 Growth and Change to 2030 is one of a series of new reports from The Business Research Company that provides interleukin inhibitors market overviews, analyzes and forecasts market size, share, interleukin inhibitors market players, interleukin inhibitors market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s interleukin inhibitors market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here is a list of similar reports from The Business Research Company:

Checkpoint Inhibitors Global Market Report 2021

TNF Alpha Inhibitors Global Market Report 2021

Protein Inhibitors Global Market Report 2021

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Check out our Blog: https://blog.tbrc.info/

Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model